IBDEI08V ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3685,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,3685,1,5,0)
 ;;=5^L/T (Current) NSAIDS Use
 ;;^UTILITY(U,$J,358.3,3685,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,3686,0)
 ;;=V58.65^^11^158^32
 ;;^UTILITY(U,$J,358.3,3686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3686,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,3686,1,5,0)
 ;;=5^L/T (Current) Steroids Use
 ;;^UTILITY(U,$J,358.3,3686,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,3687,0)
 ;;=V58.66^^11^158^27
 ;;^UTILITY(U,$J,358.3,3687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3687,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,3687,1,5,0)
 ;;=5^L/T (Current) Aspirin Use
 ;;^UTILITY(U,$J,358.3,3687,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,3688,0)
 ;;=V58.67^^11^158^29
 ;;^UTILITY(U,$J,358.3,3688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3688,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,3688,1,5,0)
 ;;=5^L/T (Current) Insulin Use
 ;;^UTILITY(U,$J,358.3,3688,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,3689,0)
 ;;=V58.68^^11^158^28
 ;;^UTILITY(U,$J,358.3,3689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3689,1,2,0)
 ;;=2^V58.68
 ;;^UTILITY(U,$J,358.3,3689,1,5,0)
 ;;=5^L/T (Current) Bisphos Use
 ;;^UTILITY(U,$J,358.3,3689,2)
 ;;=^340624
 ;;^UTILITY(U,$J,358.3,3690,0)
 ;;=V58.69^^11^158^31
 ;;^UTILITY(U,$J,358.3,3690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3690,1,2,0)
 ;;=2^V58.69
 ;;^UTILITY(U,$J,358.3,3690,1,5,0)
 ;;=5^L/T (Current) Other Meds Use
 ;;^UTILITY(U,$J,358.3,3690,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,3691,0)
 ;;=V58.83^^11^158^50
 ;;^UTILITY(U,$J,358.3,3691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3691,1,2,0)
 ;;=2^V58.83
 ;;^UTILITY(U,$J,358.3,3691,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,3691,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,3692,0)
 ;;=V62.5^^11^158^34
 ;;^UTILITY(U,$J,358.3,3692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3692,1,2,0)
 ;;=2^V62.5
 ;;^UTILITY(U,$J,358.3,3692,1,5,0)
 ;;=5^Legal Circumstances
 ;;^UTILITY(U,$J,358.3,3692,2)
 ;;=^175799
 ;;^UTILITY(U,$J,358.3,3693,0)
 ;;=V79.1^^11^159^1
 ;;^UTILITY(U,$J,358.3,3693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3693,1,2,0)
 ;;=2^V79.1
 ;;^UTILITY(U,$J,358.3,3693,1,5,0)
 ;;=5^Alcohol Screen
 ;;^UTILITY(U,$J,358.3,3693,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,3694,0)
 ;;=V61.21^^11^159^8
 ;;^UTILITY(U,$J,358.3,3694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3694,1,2,0)
 ;;=2^V61.21
 ;;^UTILITY(U,$J,358.3,3694,1,5,0)
 ;;=5^Victim Child Abuse Counseling
 ;;^UTILITY(U,$J,358.3,3694,2)
 ;;=^304301
 ;;^UTILITY(U,$J,358.3,3695,0)
 ;;=V65.40^^11^159^2
 ;;^UTILITY(U,$J,358.3,3695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3695,1,2,0)
 ;;=2^V65.40
 ;;^UTILITY(U,$J,358.3,3695,1,5,0)
 ;;=5^Counseling NOS
 ;;^UTILITY(U,$J,358.3,3695,2)
 ;;=^87449
 ;;^UTILITY(U,$J,358.3,3696,0)
 ;;=V65.42^^11^159^7
 ;;^UTILITY(U,$J,358.3,3696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3696,1,2,0)
 ;;=2^V65.42
 ;;^UTILITY(U,$J,358.3,3696,1,5,0)
 ;;=5^Substance Use/Abuse Counseling
 ;;^UTILITY(U,$J,358.3,3696,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,3697,0)
 ;;=V65.44^^11^159^3
 ;;^UTILITY(U,$J,358.3,3697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3697,1,2,0)
 ;;=2^V65.44
 ;;^UTILITY(U,$J,358.3,3697,1,5,0)
 ;;=5^HIV Counseling
 ;;^UTILITY(U,$J,358.3,3697,2)
 ;;=^303469
 ;;^UTILITY(U,$J,358.3,3698,0)
 ;;=V65.49^^11^159^5
 ;;^UTILITY(U,$J,358.3,3698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3698,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,3698,1,5,0)
 ;;=5^Oth Specified Counseling
 ;;^UTILITY(U,$J,358.3,3698,2)
 ;;=^303471
 ;;
 ;;$END ROU IBDEI08V
